Search

Search Constraints

You searched for: Author/Creator Foster, Julia

Search Results

1. A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies. Issue 2 (6th March 2022)

2. Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial. Issue 2 (February 2020)

3. Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation. Issue 2 (28th September 2017)

4. Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy. (4th February 2022)

5. Ixazomib in addition to chemotherapy for the treatment of acute lymphoblastic leukemia in older adults. Issue 6 (12th May 2022)

6. Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia. (23rd August 2018)

7. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia. Issue 15 (12th May 2016)